Signaling Pathways - MARK1 - adrenergic receptor - PKG
清除全部
- B6342 H-7 dihydrochlorideTarget: PKC|PKG|PKA|Myosin light chain kinases (MLCKs)Summary: 蛋白激酶抑制剂
- B3523 Fasudil中文名: 法舒地尔Target: ROCK|PKC|PKG|PKA|Myosin light chain kinases (MLCKs)Summary: 钙拮抗剂
- B1358 Epinephrine Bitartrate中文名: 酒石酸肾上腺素Target: adrenergic receptorSummary: 肾上腺素能受体激动剂
- B1572 LatrepirdineTarget: Voltage-gated Calcium Channels (CaV)|NMDA receptor|adrenergic receptor|Histamine receptors|GluR|5-HT receptor|dopamine receptors|AMPA receptorSummary: 脑细胞死亡抑制剂
- A5072 GSK690693Target: Akt|PKC|PKG|PKA|PrkSummary: ATP竞争性的Pan-AKT抑制剂
- A3744 Quetiapine中文名: 喹硫平Target: AChR|adrenergic receptor|5-HT receptor|Dopamine receptor|Histamine receptorSummary: 多巴胺受体拮抗剂
- A3635 MRT67307 HClTarget: TBK1|MARK1|NUAK1Summary: SIK/TBK-1/IKKe抑制剂
- A3374 Dronedarone中文名: 决奈达隆Target: Cytochrome P450 (CYP450)|sodium channel|adrenergic receptor|potassium channel|calcium channelSummary: CYP3A4和2D6抑制剂